CD79A and autoimmune polyendocrinopathy: Due to lack of a substantial body of evidence, IgA aPL are not included in current APS diagnostic criteria [1], yet some published guidelines suggest testing for IgA (particularly aβ2GPI) in patients who are IgG/IgM- and LA-negative but in whom APS is suspected [42].